Abstract
We have previously shown that calcitonin (CT), an inhibitor of bone resorption, increases vertebral, but not femoral bone density in the rat [3]. To address the physiologic responses associated with these effects on bone mineral density (BMD), we assessed mRNA transcripts reflecting activities of osteoblasts (type I collagen, osteocalcin, osteopontin, and alkaline phosphatase), osteoclasts [tartrate-resistant acid phosphatase (TRAP)], and cell proliferation (histone H4) in the spine and femur of these rats. CT increased spine BMD while increasing type I collagen and decreasing TRAP and histone mRNAs. In the femur, where CT had no effect on BMD, it decreased type I collagen and histone H4 mRNA but did not affect TRAP. CT had no effect on the gene expression of osteocalcin, osteopontin, or alkaline phosphatase at either site. The results indicate that selective alterations in gene expression, as reflected by steady state mRNA levels, are consistent with the changes observed by BMD measurement, and can more clearly define the specific contribution from osteoblast and osteoclast activity. This study demonstrates a heterogeneity in response of the axial and appendicular skeleton to CT, reflected by alterations in gene expression that provide a basis for understanding the observed BMD responses to various pharmacologic interventions.
Similar content being viewed by others
References
Ninomiya J, Tracy R, Calore J, Gendreau MA, Kelm RJ, Mann KG (1990) Heterogeneity of human bone. J Bone Miner Res 5:933–938
Civitelli R, Gonnelli S, Zacchei F, Bigazzi S, Vattimo A, Avioli L, Gennari C (1988) Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. J Clin Invest 82:1268–1274
Ongphiphadhanakul B, Alex S, Braverman LE, Baran DT (1992) Excessive L-thyroxin-therapy decreases femoral bone mineral densities in the rat: effect of hypogonadism and calcitonin. J Bone Miner Res 7:1227–1231
Shalhoub V, Jackson M, Lian J, Stein G, Marks S (1991) Gene expression during skeletal development in three osteopetrotic rat mutations. J Biol Chem 266:9847–9856
Turner R, Colvard D, Spelsberg T (1991) Measurement of mRNA levels in the periosteum of aging rats. Cells Materials (suppl) 1:47–51
Turner R, Spelsberg T (1991) Correlation between mRNA levels for bone cell proteins and bone formation in long bones of maturing rats. Am J Physiol 261:E348-E353
Ongphiphadhanakul B, Jenis LG, Braverman LE, Alex S, Stein GS, Lian JB, Baran DT (1993) Etidornate inhibits the thyroid hormone-induced bone loss in rats assessed by bone mineral density and messenger ribonucleic acid markers of osteoblast and osteoclast function. Endocrinology 133:2502–2507
Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter W (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299
Feinberg A, Vogelstein B (1983) A technique for radiolabeling DNA restriction endonuclease fragments to a high specific activity. Anal Biochem 132:6–13
Lian J, Stewart C, Puchacz E, Mackoviak S, Shalhoub V, Collart D, Zambetti G, Stein G (1989) Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl Acad Sci USA 86:1143–1147
Genovese C, Rowe D, Kream B (1984) Construction of DNA sequences complementary to rat 1 and 2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D. Biochemistry 23:6210–6216
Grimes S, Weisz-Carrington P, Daum H, Green L, Wright K, Stein G, Stein J (1987) A rat histone H4 gene closely associated with the testis-specific H1t gene. Exp Cell Res 173:534–545
Oldberg A, Franzen A, Heinegard D (1986) Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an arg-gly-asp cell-binding sequence. Proc Natl Acad Sci USA 83:8819–8823
Noda M, Yoon K, Thiede M, Buenaga R, Weiss M, Henthorn P, Harris H, Rodan G (1987) cDNA cloning of alkaline phosphatase from rat osteosarcoma (ROS 17/2.8) cells. J Bone Miner Res 2:161–164
Ketcham C, Roberts R, Simmden R, Nick H (1989) Molecular cloning of the type 5, iron-containing, tartrate-resistant acid phosphatase from human placenta. J Biol Chem 264:557–563
Wilson G, Hollar B, Waterson J, Schmickel R (1976) Molecular analysis of cloned human 18s ribosomal DNA segments. Proc Natl Acad Sci USA 75:5367–5371
Mazzuoli G, Passeri M, Gennari G, Minisola S, Antonell R, Valtorta C, Palummeri F, Cervellini G, Gonnelli S, Francini G (1986) Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study. Calcif Tissue Int 38:3–8
Avioli L (1991) Heterogeneity of osteoporotic syndromes and the response to calcitonin therapy. Calcif Tissue Int 49(suppl 2):S16-S19
Nakatsuka K, Nishizawa Y, Hagiwara S, Koyama H, Miki T, Ochi H, Morii H (1990) Effect of calcitonin on total body bone mineral contents of experimental osteoporotic rats determined by dual photon absorptiometry. Calcif Tissue Int 47:378–382
Weiss RE, Singer FR, Gorn AH, Hofer DP, Mimni ME (1981) Calcitonin stimulates bone formation when administered prior to initiation of osteogenesis. J Clin Invest 68:815–818
Lerner UH, Ransjo M, Klaushofer K, Horandner H, Hoffmann O, Czerwenka E, Koller K, Perterlik M (1989) Comparison between the effects of forskolin and calcitonin on bone resorption and osteoclastic morphology in vitro. Bone 10:377–387
Nicholson G, Mosely JM, Sexton PM, Mendelsohn F, Martin T (1986) Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. J Clin Invest 78:355–360
Chambers T, Magnus C (1982) Calcitonin alters behavior of isolated osteoclasts. J Pathol 136:27–39
Yumita S, Nicholson G, Rowe D, Kent G, Martin T (1991) Biphasic effect of calcitonin on tartrate-resistant acid phosphatase activity in isolated rat osteoclasts. J Bone Miner Res 6:591–597
Morel G, Boivin G, David L, Dubois PM, Meunier PJ (1985) Immunocytochemical evidence for endogenous calcitonin and parathyroid hormone in osteoblasts from the calvaria of neonatal mice. Calcif Tissue Int 240:89–93
Rao LG, Heersche JNM, Marchuk LL, Sturtridge W (1981) Immunohistochemical demonstration of calcitonin binding to specific cell types in fixed rat bone tissue. Endocrinology 108: 1972–1978
Farley JR, Tarbaux NM, Hall SL, Linkhart TA, Baylink DJ (1988) The anti-bone-resorptive agent calcitonin also acts in vitro to directly increase bone formation and bone cell proliferation. Endocrinology 123:159–167
Farley JR, Tarbaux NM, Vermeiden JPW, Baylink DJ (1988) In vitro evidence that local and systemic skeletal effectors can regulate 3H-thymidine incorporation in chick calvarial cell cultures and modulate the stimulatory action(s) of embryonic chick bone extract. Calcif Tissue Int 42:23–33
Farley JR, Hall SL, Tarbaux NM (1989) Calcitonin (but not calcitonin gene-related peptide) increases mouse bone cell proliferation in a dose-dependent manner, and increases mouse bone formation alone and in combination with fluoride. Calcif Tissue Int 45:214–221
Farley JR, Wergedal JE, Hall SL, Herring S, Tarbaux NM (1991) Calcitonin has direct effects on 3H-thymidine incorporation and alkaline phosphatase activity in human osteoblast-like cells. Calcif Tissue Int 48:297–301
Ito N, Yamazaki H, Nakazaki M, Miyahara T, Kozuka H, Sudo H (1987) Response of osteoblastic clonal cell line (MC3T3-E1) to (Asu1.7) eel calcitonin at a specific cell density or differentiation state. Calcif Tissue Int 40:200–205
Iida-Klein A, Yee DC, Brandli DW, Mirikitani EJM, Hahn TG (1992) Effects of calcitonin on 31, 51-cyclic adenosine monophosphate and calcium second messenger generation and osteoblast function in UMR 106-06 osteoblast-like cells. Endocrinology 130:381–388
Forrest SM, Ng KW, Findlay DM, Michelangeli VP, Livesey SA, Partridge NC, Zajac JD, Martin TJ (1985) Characterization of an osteoblast-like clonal cell line which responds to both parathyroid hormone and calcitonin. Calcif Tissue Int 37:51–56
Ferrier J, Ward-Kesthely A, Heersche JNW, Aubin JE (1988) Membrane potential changes, cAMP stimulation and contraction in osteoblast-like UMR 106 cells in response to calcitonin and parathyroid hormone. Bone Miner 4:133–145
Ferrier J, Kesthely A, Xia S-L (1992) Hormone responses of in vitro bone nodule cells: studies on changes of intracellular calcium and membrane potential in response to parathyroid hormone and calcitonin. Bone Miner 19:103–116
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jenis, L.G., Ongphiphadhanakul, B., Braverman, L.E. et al. Responsiveness of gene expression markers of osteoblastic and osteoclastic activity to calcitonin in the appendicular and axial skeleton of the rat in vivo . Calcif Tissue Int 54, 511–515 (1994). https://doi.org/10.1007/BF00334334
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00334334